Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 14, Issue 1, Pages 75-87
Publisher
Future Medicine Ltd
Online
2012-12-20
DOI
10.2217/pgs.12.185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SNPs and GVHD prediction: where to next?
- (2012) A. M. Dickinson BLOOD
- Evaluation of published single nucleotide polymorphisms associated with acute GVHD
- (2012) J. W. Chien et al. BLOOD
- Belimumab: Review of Use in Systemic Lupus Erythematosus
- (2012) Eric G. Boyce et al. CLINICAL THERAPEUTICS
- Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
- (2012) Suneet Shukla et al. DRUG RESISTANCE UPDATES
- Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function
- (2012) Ye Su et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Busulfan and Metronidazole: An Often Forgotten but Significant Drug Interaction
- (2011) Alison M Gulbis et al. ANNALS OF PHARMACOTHERAPY
- A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
- (2011) S. De Vita et al. ARTHRITIS AND RHEUMATISM
- Influence of GST Gene Polymorphisms on the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation
- (2011) Sung-Doo Kim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation
- (2011) Ngome L. Makia et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Gene expression analysis of ABC efflux transporters, CYP1A and GSTα in Nile tilapia after exposure to benzo(a)pyrene
- (2011) Joana Costa et al. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
- Relationship of drug metabolizing enzyme genotype to plasma levels as well as myelotoxicity of cyclophosphamide in breast cancer patients
- (2011) Nasir Ali Afsar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Protective effects of pine bark extract on developmental toxicity of cyclophosphamide in rats
- (2011) Sung-Hwan Kim et al. FOOD AND CHEMICAL TOXICOLOGY
- The difficulties of Polytherapy: examples from antimicrobial chemotherapy
- (2011) Teresita Mazzei Internal and Emergency Medicine
- In Vivo Prevention of Bladder Urotoxicity
- (2011) Kamel Rouissi et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children
- (2011) Zuzana Hassan PEDIATRIC TRANSPLANTATION
- Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients
- (2011) Anjali Mishra et al. SURGERY TODAY
- Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas
- (2010) SUN MI LEE et al. APMIS
- Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS
- (2010) Borje S. Andersson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Linearity and Stability of Intravenous Busulfan Pharmacokinetics and the Role of Glutathione in Busulfan Elimination
- (2010) Shlomo Almog et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT
- (2010) N Cantoni et al. BONE MARROW TRANSPLANTATION
- Oxazaphosphorines: new therapeutic strategies for an old class of drugs
- (2010) Bérénice Giraud et al. Expert Opinion on Drug Metabolism & Toxicology
- GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer
- (2010) A.L. Oliveira et al. GENETICS AND MOLECULAR RESEARCH
- Involvement of anion channels in mediating elicitor-induced ATP efflux in Salvia miltiorrhiza hairy roots
- (2010) Shu-Jing Wu et al. JOURNAL OF PLANT PHYSIOLOGY
- Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation
- (2010) Ronit Elhasid et al. PEDIATRIC BLOOD & CANCER
- A Medium-Term, Rapid Rat Bioassay Model for the Detection of Carcinogenic Potential of Chemicals
- (2010) Hiroyuki Tsuda et al. TOXICOLOGIC PATHOLOGY
- Busulfan in Hematopoietic Stem Cell Transplantation
- (2009) Stefan O. Ciurea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma
- (2009) Pooja Hingorani et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Busulfan in hematopoietic stem cell transplant setting
- (2009) Jeannine S McCune et al. Expert Opinion on Drug Metabolism & Toxicology
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Investigation of glutathione S-transferase M1 and T1 deletions in lung cancer
- (2009) Julide Altinisik et al. MOLECULAR BIOLOGY REPORTS
- Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks
- (2009) Luciano Rinaldi et al. NEUROLOGICAL SCIENCES
- Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione
- (2009) Valentina Todorova et al. NUTRITION
- Drug Focus: Pharmacogenetic studies related to cyclophosphamide-based therapy
- (2009) Navin Pinto et al. PHARMACOGENOMICS
- Genetic polymorphisms inGSTgenes and survival of colorectal cancer patients treated with chemotherapy
- (2009) Silvia Funke et al. PHARMACOGENOMICS
- Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS
- (2008) Borje S. Andersson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The effect of administration order of BU and CY on toxicity in hematopoietic SCT in humans
- (2008) F R Kerbauy et al. BONE MARROW TRANSPLANTATION
- The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model
- (2008) B Sadeghi et al. BONE MARROW TRANSPLANTATION
- A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation
- (2008) L Barkholt et al. BONE MARROW TRANSPLANTATION
- The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
- (2008) M. Bacolod et al. CURRENT CANCER DRUG TARGETS
- Endothelial cells do not express GSTA1: potential relevance to busulfan-mediated endothelial damage during haematopoietic stem cell transplantation
- (2008) Camille Vassord et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- GlutathioneS-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
- (2008) M. Isabel Lucena et al. HEPATOLOGY
- Dehydroalanine Analog of Glutathione: An Electrophilic Busulfan Metabolite That Binds to Human Glutathione S-Transferase A1-1
- (2008) I. R. Younis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia
- (2008) V Rocha et al. LEUKEMIA
- Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure
- (2008) R. Nagasubramanian et al. MUTAGENESIS
- Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma
- (2008) Nadia Barahmani et al. NEURO-ONCOLOGY
- Do glutathione-S-transferase polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephrotic syndrome?
- (2008) Sheetal V. Sharda et al. PEDIATRIC NEPHROLOGY
- Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin
- (2008) Corine Ekhart et al. Pharmacogenetics and Genomics
- Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide
- (2008) Corine Ekhart et al. Pharmacogenetics and Genomics
- Urological implications of cyclophosphamide and ifosfamide
- (2008) Malcolm Lawson et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Serious haematological toxicity of cyclophosphamide in relation to CYP2B6, GSTA1 and GSTP1 polymorphisms
- (2007) Agnès Tran et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic polymorphisms of human cytosol glutathioneS-transferases and prostate cancer
- (2007) Takahiko Katoh et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search